Short-term PsychoEducation for Carers To Reduce Over Medication of people with intellectual disabilities (SPECTROM): study protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
08 04 2020
Historique:
entrez: 11 4 2020
pubmed: 11 4 2020
medline: 21 4 2021
Statut: epublish

Résumé

Psychotropic medications that are primarily licenced for the treatment of psychiatric disorders are used widely (32%-85%) among people with intellectual disabilities (ID) often for the management of problem (challenging) behaviour in the absence of a psychiatric disorder. Care staff play a pivotal role in the prescribing process. Currently, no staff training programme exists to address the issue of overprescribing of psychotropic medication in people with ID, thus highlighting an urgent need for developing a psychoeducational programme (PEP) specifically designed to address this issue. We propose to develop a PEP for care staff using the methodology described in the UK Medical Research Council guide for complex interventions. The development of the PEP will involve (1) gathering information on available relevant training programmes, (2) running four focus groups with care staff and other professionals to establish the content and format of the PEP, and (3) organising a co-design event involving all relevant stakeholders to discuss the format of the PEP. A core project team will develop the PEP under guidance from the PEP Development Group which will consist of 10-12 relevant stakeholder representatives. Feedback from selected stakeholders on a draft PEP will allow us to refine the PEP before implementation. The PEP will have web-based modules supplemented by face to face training sessions. When the final draft is ready, we will field test the PEP on six to eight care staff from community care homes for people with ID. After completing the field test, we will run a focus group involving participants in the PEP to get feedback on the PEP. Ethics approval for this study was waived by the UK Health Regulatory Authority as the study does not collect any patient related information and only include care staff outside the UK NHS. This will be the first ever such universally freely available PEP supported by training manual and slides.

Identifiants

pubmed: 32273322
pii: bmjopen-2020-037912
doi: 10.1136/bmjopen-2020-037912
pmc: PMC7245413
doi:

Substances chimiques

Psychotropic Drugs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e037912

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Ment Defic Res. 1990 Oct;34 ( Pt 5):385-95
pubmed: 2266549
BMJ. 2015 Sep 01;351:h4326
pubmed: 26330451
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Lancet Psychiatry. 2017 Mar;4(3):238-256
pubmed: 27838214
World Psychiatry. 2009 Oct;8(3):181-6
pubmed: 19812757
BMJ. 2006 Apr 1;332(7544):756-61
pubmed: 16543297
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
BMC Fam Pract. 2005 Jul 27;6:30
pubmed: 16048645
Cochrane Database Syst Rev. 2012 Dec 12;12:CD008634
pubmed: 23235663
J Appl Res Intellect Disabil. 2017 Dec;30 Suppl 1:1-9
pubmed: 28467003
J Health Econ. 2002 Mar;21(2):271-92
pubmed: 11939242
J Adv Nurs. 2008 Jun;62(5):596-606
pubmed: 18489452
Qual Saf Health Care. 2006 Oct;15(5):307-10
pubmed: 17074863
BMJ Open. 2017 Aug 3;7(8):e017406
pubmed: 28775195
J Intellect Disabil Res. 2007 Sep;51(Pt 9):726-39
pubmed: 17845241
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777

Auteurs

Shoumitro Deb (S)

Division of Psychiatry, Faculty of Medicine, Department of Brain Sciences, Imperial College London, London, UK s.deb@imperial.ac.uk.

Bharati Limbu (B)

Division of Psychiatry, Faculty of Medicine, Department of Brain Sciences, Imperial College London, London, UK.

Mike Crawford (M)

Division of Psychiatry, Faculty of Medicine, Department of Brain Sciences, Imperial College London, London, UK.

Tim Weaver (T)

Department of Mental Health Research, School of Health and Education, Middlesex University, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH